PAK5 and breast carcinoma: In the current study, we evaluated PAK5 and p65 staining in breast cancer tissues (BCTs) and paired non-cancerous tissues (NTs) using tissue microarray (TMA) technology and analyzed the correlation between PAK5 as well as p65 expression and clinicopathologic features.